Zymeworks CEO Ali Tehrani's 2021 pay rises 5% to $5.1M

Zymeworks reports 2021 executive compensation

By ExecPay News

Published: November 25, 2022

Zymeworks reported fiscal year 2021 executive compensation information on November 25, 2022.
In 2021, six Zymeworks executives received on average a compensation package of $2.6M, a 2% decrease compared to previous year.
Average pay of disclosed executives at Zymeworks
Ali Tehrani, Chief Executive Officer, received $5.1M in total, which increased by 5% compared to 2020. 71% of Tehrani's compensation, or $3.6M, was in option awards. Tehrani also received $593K in salary, $871K in stock awards, as well as $22K in other compensation.
Neil Josephson, Chief Medical Officer, received a compensation package of $3.5M. 71% of the compensation package, or $2.5M, was in option awards.
Anthony Polverino, Chief Scientific Officer, earned $1.9M in 2021, a 1% increase compared to previous year.
Neil Klompas, Chief Financial Officer, received $1.9M in 2021, which increases by 1% compared to 2020.
Diana Hausman, Chief Medical Officer, earned $1.6M in 2021, a 15% decrease compared to previous year.
James Priour, Former Chief Commercial Officer, received $1.5M in 2021.

Related executives

Ali Tehrani

Zymeworks

Chief Executive Officer

Neil Klompas

Zymeworks

Chief Operating Officer

Neil Josephson

Zymeworks

Chief Medical Officer

Anthony Polverino

Zymeworks

Chief Scientific Officer

James Priour

Zymeworks

Former Chief Commercial Officer

Diana Hausman

Zymeworks

Chief Medical Officer

You may also like

Source: SEC filing on November 25, 2022.